Oral presentation at the 18th annual event of ETPN & the 5th NME conference merged into a unique event: NanoMed Europe 23 (NME23)
Shortlisted for the Best SEIS Investee Company category in the EISA Awards 2023 Article about the award day see: IF Magazine
Named finalist in the Royal Society of Chemistry Emerging Technology Competition in the health category
Oral presentation at the International Society for Therapeutic Ultrasound (ISTU) annual symposium
Science Entrepreneur Club has spotlighted Apeikon Therapeutics, described our technology
Attended to BioSeed 2023 in London, a European equity investment event for early-stage life science companies.
Founder Maya Thanou was nominated by Cancer Research Horizon as one of the top 5 women entrepreneurs in the field of cancer technologies in the UK.
Apeikon was selected to participate in King’s College London’s King’s 20 Accelerator Program, which is recognised as the flagship program of the Entrepreneurship Institute
Poster presentation at the New Modalities in Pharmacology & Drug Discovery 2022, which is a joint conference hosted by BPS (British Pharmacological Society) and ELRIG UK
Selected to participate in the WAPG Launch programme